Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Chorea associated with Huntington disease |
Dose: Oral – 6 mg Frequency: once daily Note: Initial dose when not being switched from tetrabenazine. Dose is determined individually for each patient based on reduction of chorea and tolerability. May increased dose at weekly intervals in increments of 6 mg/day; not to exceed 48 mg/day. Administer doses greater than 12 mg/day in 2 divided doses. |
|
Indication: Tardive Dyskinesia |
Dose: Oral – 6 mg Frequency: twice daily Note: Initial dose when not being switched from tetrabenazine. Dose is determined individually for each patient based on reduction of tardive dyskinesia and tolerability. May increased dose at weekly intervals in increments of 6 mg/day; not to exceed 48 mg/day. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Not applicable – No approved dosage Note: No approved pediatric dosage available |
Administration
- Take with food
- Take at same time each day
Side Effect
- Somnolence (11%)
- Diarrhea (9%)
- Dry mouth (9%)
- Fatigue (9%)
- Urinary Tract Infection (UTI) (7%)
- Insomnia (7%)
- Anxiety (4%)
- Constipation (4%)
- Contusion (4%)
- Dizziness (4%)
- Akathisia, agitation or restlessness (4%)
- Depression in patients with Huntington’s disease (4%)
- Suicidal ideation in patients with Huntington’s disease (2%)
- Parkinsonism in patients with Huntington’s disease
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Dopamine antagonists, Antipsychotics (Haloperidol, Risperidone, Quetiapine, Olanzapine, Clozapine, Aripiprazole)
|
May increase risk for parkinsonism, NMS, and akathisia
|
|
Alcohol, sedating drugs
|
May worsen somnolence associated with deutetrabenazine
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Suicidal Patients with Huntington Disease
|
Risk of suicide attempt
|
|
Untreated/Inadequately Treated Depression
|
Risk of worsening depression
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.